Literature DB >> 9071216

Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.

K M Hämäläinen1, K Kananen, S Auriola, K Kontturi, A Urtti.   

Abstract

PURPOSE: To characterize quantitatively the paracellular permeation routes in rabbit cornea, conjunctiva, and sclera using polyethylene glycol (PEG) oligomers.
METHODS: Corneal, conjunctival, and scleral tissues from New Zealand white rabbits were tested individually in a modified two-chamber Ussing apparatus with the mixture of PEGs with mean molecular weights 200, 400, 600, and 1000 in glutathione bicarbonated Ringer's solution buffer on the donor side of the chamber. The samples and standards were analyzed with high-performance liquid chromatography-thermospray mass spectrometry method. The pore sizes and the pore densities of the corneal and conjunctival epithelia were calculated using an effusion-like approach.
RESULTS: The conjunctival and scleral tissues were 15 to 25 times more permeable than the cornea and the molecular size affected the conjunctival permeability less than that of the cornea. The palpebral and bulbar conjunctivas had equal permeabilities. The scleral permeability was approximately half of that in the conjunctiva and approximately 10 times more than in the cornea. The conjunctival epithelia had 2 times larger pores and 16 times higher pore density than the cornea. The total paracellular space in the conjunctiva was estimated to be 230 times greater than that in the cornea.
CONCLUSIONS: The conjunctival epithelium, due to its higher membrane permeability and larger absorptive and intercellular space surface areas, is the most viable route for ocular delivery of peptides and oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071216

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  41 in total

1.  Ocular Distribution of Papaverine Using Non-aqueous Vehicles.

Authors:  Priyanka Agarwal; Sairam Behera; Ilva Dana Rupenthal
Journal:  AAPS PharmSciTech       Date:  2021-05-24       Impact factor: 3.246

Review 2.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Polar solute transport across the pigmented rabbit conjunctiva: size dependence and the influence of 8-bromo cyclic adenosine monophosphate.

Authors:  Y Horibe; K Hosoya; K J Kim; T Ogiso; V H Lee
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 4.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

5.  In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.

Authors:  Tamara Martínez; Maria Victoria González; Ingo Roehl; Natalia Wright; Covadonga Pañeda; Ana Isabel Jiménez
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

6.  Influence of format on in vitro penetration of antibody fragments through porcine cornea.

Authors:  H M Brereton; S D Taylor; A Farrall; D Hocking; M A Thiel; M Tea; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

7.  [Pharmacokinetics of the anterior eye].

Authors:  K Bell; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

Review 8.  Gene delivery to cornea.

Authors:  Jinsong Hao; S Kevin Li; Winston W Y Kao; Chia-Yang Liu
Journal:  Brain Res Bull       Date:  2009-06-26       Impact factor: 4.077

Review 9.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

Review 10.  Mucosal immune tolerance at the ocular surface in health and disease.

Authors:  Jeremías G Galletti; Mauricio Guzmán; Mirta N Giordano
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.